The Indian drugmaker reported certain batches were out of specification due to an issue associated with the active pharmaceutical ingredient used in the product.
The inspection clears the Hebei manufacturing site to support commercial production of an investigational autoimmune therapy with blockbuster potential.
UV is a comprehensive solution for chloramine reduction and can work synergistically with activated carbon, helping to reduce waste, lower operating costs, and minimize the amount of carbon needed over time.
